Company Search:
Advanced Search
Sponsored Links
Enzymotec Ltd Company Snapshot
Enzymotec Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Enzymotec Ltd with three other pharmaceutical manufacturers in Middle East: Alexandria Pharmaceuticals and Chemical Industries Co of Egypt (2016 sales of 424.96 million Egyptian Pounds [US$23.98 million] ), Dar Al Dawa Development & Investment of Jordan (60.88 million Jordanian Dinars [US$85.74 million] of which 80% was Pharmaceuticals), and Glaxo Smith Kline which is based in Egypt (1.17 billion Egyptian Pounds [US$65.78 million] of which 93% was Medical Sector).

Sales Analysis. During the year ended December of 2016, sales at Enzymotec Ltd were 182.39 million Israel Shekels (US$53.47 million). This is a decrease of 6.9% versus 2015, when the company's sales were 195.82 million Israel Shekels. Contributing to the drop in overall sales was the 9.8% decline in Nutrition, from 210.48 million Israel Shekels to 189.90 million Israel Shekels. . However, these declines were partially offset by the increase in sales of Vaya Pharma (up 30.3% to 42.88 million Israel Shekels) .
  Stock Performance Chart for Enzymotec Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/5/2018): 40.73
(Figures in Israel Shekels)
1 Week -1.2%   13 Weeks -2.4%  
4 Weeks 3.8%   52 Weeks 47.1%  
Enzymotec Ltd Key Data:
  Ticker: ENZY Country: Israel
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 182,393,797
(Year Ending Jan 2017).
Employees: 124
  Currency: Israel Shekels Market Cap: 954,190,159
  Fiscal Yr Ends: December Shares Outstanding: 23,428,099
  Share Type: Ordinary Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.